Crestal Bone Loss Around Submerged and Non-Submerged Dental Implants in Individuals with Type-2 Diabetes Mellitus: A 7-Year Prospective Clinical Study
- PMID: 30396170
- PMCID: PMC6558320
- DOI: 10.1159/000495111
Crestal Bone Loss Around Submerged and Non-Submerged Dental Implants in Individuals with Type-2 Diabetes Mellitus: A 7-Year Prospective Clinical Study
Abstract
Objective: In establishing an evidence-based rationale for the optimal use of implant therapy in patients with type 2 diabetes mellitus (T2DM), it is essential to first understand the impact of glycemic control on early healing and the success of dental implants. The objective of this study was to evaluate crestal bone loss (CBL) and stability around submerged and non-submerged dental implants in Saudi patients with well- and poorly controlled T2DM.
Subject and methods: Thirty-five patients with well-controlled T2DM (24 males and 11 females) and 32 poorly controlled T2DM patients (19 males and 13 females) were included. CBL was measured on digital radiographs; resonance frequency analysis (RFA) measurements were made for each implant at the time of fixture placement and at 3 months in both the groups. A p value less than 0.05 was considered statistically significant.
Results: A total of 124 dental implants were placed. Mean RFA values between baseline and 3 months in poorly controlled T2DM patients was statistically significant (p = 0.048). CBL at first year (p = 0.047), second year (p = 0.041), third year (p = 0.046), and seventh year (p = 0.035) was significantly worse in poorly controlled T2DM. CBL around non-submerged dental implants showed statistically significant differences at all time-intervals (p < 0.05).
Conclusion: Poorly controlled T2DM patients present worse peri-implant bone outcomes as compared to patients with well-controlled T2DM. We suggest that the predictability of successful dental implant therapy outcomes depends on the maintenance of optimal haemoglobin A1c levels.
Keywords: Alveolar bone loss; Dental implants; Diabetes mellitus; Resonance frequency analysis.
© 2018 The Author(s) Published by S. Karger AG, Basel.
Figures
Similar articles
-
Stability and bone loss around submerged and non-submerged implants in diabetic and non-diabetic patients: a 7-year follow-up.Braz Oral Res. 2018 Jul 10;32:e57. doi: 10.1590/1807-3107bor-2018.vol32.0057. Braz Oral Res. 2018. PMID: 29995063 Clinical Trial.
-
Peri-implant soft tissue status and crestal bone levels around adjacent implants placed in patients with and without type-2 diabetes mellitus: 6 years follow-up results.Clin Implant Dent Relat Res. 2018 Aug;20(4):562-568. doi: 10.1111/cid.12617. Epub 2018 May 22. Clin Implant Dent Relat Res. 2018. PMID: 29787632
-
Influence of Glycemic Control on the Survival of Implants Placed in the Zygomatic Bone of Edentulous Patients With and Without Type 2 Diabetes Mellitus: 10-Year Follow-Up Results.J Oral Implantol. 2022 Feb 1;48(1):21-26. doi: 10.1563/aaid-joi-D-20-00261. J Oral Implantol. 2022. PMID: 33270895
-
Current status of dental implants survival and peri-implant bone loss in patients with uncontrolled type-2 diabetes mellitus.Curr Opin Endocrinol Diabetes Obes. 2019 Aug;26(4):219-222. doi: 10.1097/MED.0000000000000482. Curr Opin Endocrinol Diabetes Obes. 2019. PMID: 31145131 Review.
-
Dental implants and diabetes: conditions for success.Diabetes Metab. 2012 Feb;38(1):14-9. doi: 10.1016/j.diabet.2011.10.002. Epub 2012 Jan 27. Diabetes Metab. 2012. PMID: 22284547 Review.
Cited by
-
Should Quality of Glycemic Control Guide Dental Implant Therapy in Patients with Diabetes? Focus on: Peri-Implant Diseases.Clin Cosmet Investig Dent. 2021 Apr 21;13:149-154. doi: 10.2147/CCIDE.S297467. eCollection 2021. Clin Cosmet Investig Dent. 2021. PMID: 33911902 Free PMC article. Review.
-
Current Knowledge Regarding the Interaction Between Oral Bone Metabolic Disorders and Diabetes Mellitus.Front Endocrinol (Lausanne). 2020 Aug 7;11:536. doi: 10.3389/fendo.2020.00536. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32903738 Free PMC article. Review.
-
miR-153-3p inhibits osteogenic differentiation of BMSCs by down-regulating the expression of RUNX2 in a high glucose environment.Am J Transl Res. 2022 Oct 15;14(10):7027-7039. eCollection 2022. Am J Transl Res. 2022. PMID: 36398274 Free PMC article.
-
Systematic review on diabetes mellitus and dental implants: an update.Int J Implant Dent. 2022 Jan 3;8(1):1. doi: 10.1186/s40729-021-00399-8. Int J Implant Dent. 2022. PMID: 34978649 Free PMC article.
-
Immediate implant-prosthetic dental rehabilitation of patients with diabetes using four immediately loaded dental implants: a pilot study.J Int Med Res. 2020 Mar;48(3):300060519897195. doi: 10.1177/0300060519897195. J Int Med Res. 2020. PMID: 32228306 Free PMC article. Clinical Trial.
References
-
- American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37(Suppl 1):S81–90. - PubMed
-
- Dowell S, Oates TW, Robinson M. Implant success in people with type 2 diabetes mellitus with varying glycemic control: a pilot study. J Am Dent Assoc. 2007 Mar;138((3)):355–61. - PubMed
-
- Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr Diabetes Rev. 2017;13((1)):59–64. - PubMed
-
- Mealey BL, Oates TW, American Academy of Periodontology Diabetes mellitus and periodontal diseases. J Periodontol. 2006 Aug;77((8)):1289–303. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous